A2PG

Ann Arbor, United States Founded: 2007 • Age: 19 yrs Acquired By Amador
Data management, pharmacokinetics, and CRO services are provided by A2PG.

About A2PG

A2PG is a Healthcare company based in Ann Arbor (United States) founded in 2007 by Matt Hutmacher, and was acquired by Amador in December 2021. Data management, pharmacokinetics, and CRO services are provided by A2PG. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its competitors include Charles River Laboratories, LabCorp and Cytel; 1 of its 3 listed competitors has raised funding.

Company details

A2PG was established in 2007 in Ann Arbor, United States, as a contract research organization (CRO). Services encompassing data management, pharmacokinetics, and related support are delivered to clients in the pharmaceutical and biotechnology sectors. Operations focus on analytical and consulting tasks, with expertise contributed by co-founder Matt Hutmacher. The company maintains a presence in the U.S. healthcare research landscape, supporting drug development processes through specialized tools and methodologies.

  • Headquarters Ann Arbor, United States
  • Founders Matt Hutmacher
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website a2pg.com
  • Acquired by Amador (Dec 2021)
Key Metrics

Investors in A2PG

A2PG has secured backing from 1 investor. Prominent investors backing the company include Amador.

All
InvestorDescriptionFounded YearDomainLocation
Bioanalytical, pharmacometrics, and related services are provided to clients.
2018amadorbioscience.comPleasanton, United States
Premium access

Investor details for A2PG

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of A2PG

1 people are tracked at A2PG (1 in leadership).

NameRoleGroup
Matt Hutmacher
Co-FounderLeadership
Premium access

Complete people profiles for A2PG

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of A2PG

2 dated milestones of A2PG across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded A2PG is founded.
  2. Exit Acquired by Amador.

Competitors of A2PG

A2PG has 3 listed competitors in our database, 1 of them funded. They include Charles River Laboratories, LabCorp and Cytel.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
criver.com1947Wilmington, United States21,400
Provider of drug discovery and preclinical development services
labcorp.com1969Burlington, United States9,321
Provider of laboratory tests for physicians
cytel.com1987Cambridge, United States$2M509
Data analysis and statistical solutions are provided for life sciences.
Premium access

Detailed competitors of A2PG

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as A2PG (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about A2pg

Premium access

Complete news archive for A2PG

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about A2PG

A2PG was founded in 2007.

A2PG is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.

A2PG was established in 2007 in Ann Arbor, United States, as a contract research organization (CRO). Services encompassing data management, pharmacokinetics, and related support are delivered to clients in the pharmaceutical and biotechnology sectors. Operations focus on analytical and consulting tasks, with expertise contributed by co-founder Matt Hutmacher. The company maintains a presence in the U.S. healthcare research landscape, supporting drug development processes through specialized tools and methodologies.

A2PG's top competitors include LabCorp, Charles River Laboratories and Cytel.

A2PG has 1 investor. Key investors include Amador.

Yes. A2PG was acquired by Amador in December 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available